Clinical Trial Update: Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zidovudine plus interleukin-2 and ganciclovir for AIDS-related primary central nervous system lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Primary Central Nervous System Lymphoma

Drugs mentioned

• Cytovene (ganciclovir)
• Proleukin (aldesleukin)
• RETROVIR (Zidovudine)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Lymphoma | Phase 2 | Status: COMPLETED